The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 101–200 of 1,810
Lu, S., Wang, J., Kakongoma, N., Hua, W., Xu, J., Wang, Y., He, S., Gu, H., Shi, J., & Hu, W. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01289-5 · Cited by 53
“Increased insulin resistance and impaired insulin secretion are the main causes of GDM [4].”
BackgroundCell death mechanisms and their roles in pregnancy related disorders
Kasture, V., Sahay, A. S., & Joshi, S. (2021) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.01.006 · Cited by 43
Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development—An Overview
Dawid, M., Mlyczyńska, E., Jurek, M., Respekta, N., Pich, K., Kurowska, P., Gieras, W., Milewicz, T., Kotula‐Balak, M., & Rak, A. (2021) · Cells · doi:10.3390/cells11010099 · Cited by 48
Mercado-Evans, V., Mejia, M. E., Zulk, J. J., Ottinger, S., Hameed, Z. A., Serchejian, C., Marunde, M. G., Robertson, C. M., Ballard, M. B., Ruano, S. H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45336-6 · Cited by 40
The Role of Adiponectin during Pregnancy and Gestational Diabetes
Gruber, B. L. M., & Dolinsky, V. W. (2023) · Life · doi:10.3390/life13020301 · Cited by 55
“GDM may develop when compensatory mechanisms are insufficient to overcome the insulin resistance of pregnancy, which is associated with excessive gestational weight gain or obesity that precedes pregnancy [53].”
BackgroundSong, T., Su, G., Chi, Y., Wu, T., Xu, Y., & Chen, C. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1940932 · Cited by 46
The Role of Xanthine Oxidase in Pregnancy Complications: A Systematic Review
Annesi, L., Tossetta, G., Borghi, C., & Piani, F. (2024) · Antioxidants · doi:10.3390/antiox13101234 · Cited by 49
“Adequate extravillous trophoblast invasion and rapid villous angiogenesis are crucial for proper placental development and subsequent fetal growth.”
BackgroundOrtega, M. A., Fraile‐Μartinez, O., Montero, C. G., Paradela, A., Sánchez-Gil, M. A., Rodriguez-Martín, S., León-Luis, J. A. D., Pereda-Cerquella, C., Buján, J., Guijarro, L. G., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1060850 · Cited by 52
“The main risk factors for GDM are obesity, sedentary lifestyle, multiparity, family history of type 2 diabetes mellitus (T2DM), past history of GDM or delivery of a macrosomic baby, advanced maternal age, ethnicity and polycystic ovarian syndrome (Lin et al., 2016; Yaping et al., 2022).”
BackgroundGarg, N. B., Arunan, S. K., Arora, S., & Kaur, K. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820965577 · Cited by 45
Doi, S. A. R., Furuya‐Kanamori, L., Toft, E., Musa, O. A. H., Islam, N., Clark, J., & Thalib, L. (2020) · Obesity Reviews · doi:10.1111/obr.12964 · Cited by 39
“In most cases, this hyperglycaemia is the result of impaired glucose tolerance due to pancreatic beta‐cell dysfunction on a background of chronic insulin resistance.(1) Consequences of GDM include increased risk of maternal cardiovascular disease and type 2 diabetes and macrosomia and birth complications in the infant.”
BackgroundInfluentialContinuous Glucose Monitoring in Women with Normal OGTT in Pregnancy
Tartaglione, L., Stasio, E. D., Sirico, A., Leo, M. A. S. D., Caputo, S., Rizzi, A., Caneschi, A., Carolis, S. D., Pitocco, D., & Lanzone, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9987646 · Cited by 43
“Macrosomia for the fetus and type 2 diabetes for the mother are the main adverse outcomes in GDM. Maternal blood glucose signi fi - cantly a ff ects fetal growth, and glycemic control is essential for adequate diabetes management [6].”
Huang, X., Zha, B., Zhang, M., Li, Y., Wu, Y., Zhang, R., Sheng, L., Xu, J., Yu, Z., Gao, C., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab657 · Cited by 44
Zukin, H., Eskenazi, B., Holland, N., & Harley, K. G. (2021) · Environmental Research · doi:10.1016/j.envres.2021.110712 · Cited by 38
“In GDM, pancreatic beta cells do not produce sufficient amounts of insulin to overcome this natural state of insulin resistance (Plows et al. 2018).”
BackgroundDysglycemia in Pregnancy and Maternal/Fetal Outcomes
Silva, C. M., Arnegard, M. E., & Maric‐Bilkan, C. (2021) · Journal of Women s Health · doi:10.1089/jwh.2020.8853 · Cited by 47
“Maternal hyperglycemia leads to fetal b cell hyperplasia and increased endogenous production of insulin and insulin-like growth factor 1.(42) The resultant fetal hyperinsulinemia lowers fetal glucose levels, thus increasing the glucose concentration gradient across the placenta, driving glucose flux to the fetus.”
BackgroundMahai, G., Wan, Y., Wang, A., Qian, X., Li, J., Li, Y., Zhang, W., He, Z., Li, Y., Xia, W., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108173 · Cited by 44
Zhang, T., Wang, S., Li, L., Zhu, A., & Wang, Q. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153932 · Cited by 38
Thyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship
Pinto, S., Croce, L., Lea, C., Cosson, E., & Rotondi, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02079-3 · Cited by 44
“In the first part of gestation an anabolic state establishes in preparation for the energy demands of later pregnancy; this state is characterized by normal or slightly higher insulin sensitivity to promote the glucose uptake by liver and muscle and subsequent reduced fasting glycemia [13, 14].”
BackgroundUnveiling the pathophysiology of gestational diabetes: Studies on local and peripheral immune cells
Luccia, T. P. D. B. D., Pendeloski, K. P. T., Ono, É., et al. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12860 · Cited by 37
Gestational diabetes mellitus induces placental vasculopathies
Aldahmash, W., Alwasel, S. H., & Aljerian, K. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17267-y · Cited by 45
“Gestational diabetes mellitus is associated with an increased risk for macrosomia and cesarean delivery; it can lead to later maternal complications, such as type 2 diabetes mellitus and cardiovascular disease, and it has been associated with pregnancy-related disorders, such as preterm premature rupture of membranes…”
Yao, X., Liu, R., Li, X., Yan, L., Zhang, Z., Huang, S., Ge, Y., Chen, X., & Yang, X. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108810 · Cited by 47
Igf2 deletion alters mouse placenta endocrine capacity in a sexually dimorphic manner
Aykroyd, B. R. L., Tunster, S. J., & Sferruzzi-Perri, A. N. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0128 · Cited by 34
Leone, A., Martínez-González, M. Á., Craig, W., Fresán, U., Gómez-Donoso, C., & Bes-Rastrollo, M. (2021) · Nutrients · doi:10.3390/nu13072202 · Cited by 36
Gámez-Valdez, J. S., García-Mazcorro, J. F., Rincón, A. H. M., Rodríguez-Reyes, D. L., Blanco, G. J., Rodríguez, M. T. A., de Vaca, R. P., Alcorta-García, M. R., Brunck, M. E. G., Díaz, V. J. L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03779-7 · Cited by 44
Abu Samra, N., Jelinek, H. F., Alsafar, H., Asghar, F., Seoud, M., Hussein, S. M., Mubarak, H. M., Anwar, S., Memon, M., Afify, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073514 · Cited by 36
“This is suggested to be mediated via placental hormones including: human placental growth (hPG), human placental lactogen (hPL), cortisol, estrogen, and progesterone, in addition to chronic inflammation factors like tumor necrosis factor α (TNF-α) [1,2,4].”
BackgroundInfluentialNabhani, Z., Clark, C. C. T., Goudarzi, N., Far, A. H., & Razmpoosh, E. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00858-1 · Cited by 39
“Insulin resistance may develop as the pregnancy advances into the third trimester due to additional hormones released during the pregnancy that might impair the efficacy of insulin and induce hyperglycemia [4].”
BackgroundTian, M., Ma, S., You, Y., Long, S., Zhang, J., Guo, C., Wang, X., & Tan, H. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8885954 · Cited by 41
HtrA1 in Gestational Diabetes Mellitus: A Possible Biomarker?
Tossetta, G., Fantone, S., Gesuita, R., Renzo, G. C. D., Meyyazhagan, A., Tersigni, C., Scambia, G., Simone, N. D., & Marzioni, D. (2022) · Diagnostics · doi:10.3390/diagnostics12112705 · Cited by 43
“It has been suggested that chronic low-level inflammation is one of the most important causes of insulin resistance onset, since chronic exposure to pro-inflammatory cytokines can impair insulin signaling pathways and decrease insulin secretion from beta cells [5].”
BackgroundSubiabre, M., Villalobos-Labra, R., Silva, L., Fuentes, G., Toledo, F., & Sobrevía, L. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.021 · Cited by 37
Expression of nutrient transporters in placentas affected by gestational diabetes: role of leptin
Guadix, P., Corrales-Gutiérrez, I., Vilariño‐García, T., Rodríguez-Chacón, C., Sánchez-Jiménez, F., Jiménez‐Cortegana, C., Dueñas, J. L., Sánchez‐Margalet, V., & Pérez‐Pérez, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1172831 · Cited by 41
Pajunen, L., Korkalo, L., Koivuniemi, E., Houttu, N., Pellonperä, O., Mokkala, K., Shivappa, N., Hébert, J. R., Vahlberg, T. J., Tertti, K., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02749-z · Cited by 51
“Another mechanism how nutrients could affect the development of GDM is their effects on glucose and insulin metabolism as these are important factors in the pathophysiology of GDM [26].”
BackgroundPlows, J. F., Morton-Jones, J., Bridge-Comer, P. E., Ponnampalam, A. P., Stanley, J. L., Vickers, M. H., & Reynolds, C. M. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa106 · Cited by 36
Self-citationGestational diabetes and childhood asthma in a racially diverse US pregnancy cohort
Adgent, M. A., Gebretsadik, T. S., Reedus, J., Graves, C. R., Garrison, E., Bush, N. R., Davis, R. L., LeWinn, K. Z., Tylavsky, F. A., & Carroll, K. N. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13523 · Cited by 37
Role of chemerin in the control of glucose homeostasis
Léniz, A., González, M. A., Besné-Eseverri, I., Carr-Ugarte, H., Gómez-García, I., & Portillo, M. P. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111504 · Cited by 39
Ramezani Tehrani, F., Naz, M. S. G., Yarandi, R. B., & Behboudi-Gandevani, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040666 · Cited by 34
“Chronic disturbances in maternal β-cell, release of diabetogenic peptides from the placenta, and hormones may play a key role in the pathophysiology of GDM [5].”
BackgroundNovel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0
Ruszała, M., Pilszyk, A., Niebrzydowska-Tatus, M., Kimber-Trojnar, Ż., Trojnar, M. P., & Leszczyńska‐Gorzelak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084364 · Cited by 44
“Given the various diagnostic criteria and ethnicity, in many countries the epidemiology of GDM still remains unknown [8,9].”
BackgroundXue, C., Xie, Q., Zhang, C., Hu, Y., Song, X., Jia, Y., Shi, X., Chen, Y., Liu, Y., Zhao, L., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01318-8 · Cited by 35
“HIP not only causes β cell dysfunction and insulin resistance in children [4, 5], but also confers an almost doubled risk of developing T2DM later in life [6, 7].”
BackgroundMiR-193b inhibits autophagy and apoptosis by targeting IGFBP5 in high glucose-induced trophoblasts
Ji, Y., Zhang, W., Yang, J., & Li, C. (2020) · Placenta · doi:10.1016/j.placenta.2020.09.015 · Cited by 36
Garnweidner-Holme, L. M., Henriksen, L., Torheim, L. E., & Lukasse, M. (2020) · JMIR mhealth and uhealth · doi:10.2196/18614 · Cited by 39
“Even though GDM resolves in most women after delivery, its development may affect the health of both mothers and children in the short and long terms [7,8].”
Immunobiology of Gestational Diabetes Mellitus in Post-Medawar Era
Sharma, S., Banerjee, S., Krueger, P. M., & Blois, S. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758267 · Cited by 39
“Inflammation: Recent evidence suggests that GDM is not only an issue of increased insulin resistance and glucose intolerance, but also a condition of low-grade systemic and placental inflammation (39).”
BackgroundNguyen‐Ngo, C., Willcox, J. C., & Lappas, M. (2020) · Placenta · doi:10.1016/j.placenta.2020.08.002 · Cited by 38
Biochemical and Molecular Biomarkers: Unraveling Their Role in Gestational Diabetes Mellitus
Karami, M., Mousavi, S. H., Rafiee, M., Heidari, R., & Shahrokhi, S. Z. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00980-8 · Cited by 33
“Finally, declined insulin sensitivity related to a normal pregnancy disappears within days of birth, indicating that these alterations are mediated by placental hormones [27].”
BackgroundPhysical activity in pregnancy prevents gestational diabetes: A meta-analysis
Doi, S. A. R., Furuya-Kanamori, L., Toft, E., Musa, O. A. H., Mohamed, A. M., Clark, J., & Thalib, L. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108371 · Cited by 33
“The rationale for the latter is that GDM is linked to insulin resistance on a backdrop of beta-cell dysfunction [9] and such interventionsmodulate insulin sensitivity due to their possible effect on gestational weight gain [7].”
BackgroundHassan, I., Ebaid, H., Al‐Tamimi, J., Habila, M. A., Alhazza, I. M., & Rady, A. M. (2020) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2020.101265 · Cited by 39
Vavrečková, M., Galanová, N., Kostovčík, M., Krystyník, O., Ivanovová, E., Roubalová, R., Zakostelska, Z. J., Friedecký, D., Friedecká, J., Haluzík, M., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.970825 · Cited by 41
“These two subtypes differ in their pathophysiological mechanisms and also in the severity of health complications associated with GDM (16).”
BackgroundUpdate on gestational diabetes and adverse pregnancy outcomes
Ugwudike, B., & Kwok, M. H. (2023) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000901 · Cited by 38
Sisay, M., Edessa, D., Ali, T., Mekuria, A. N., & Gebrie, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240382 · Cited by 37
“Available evidence indicated that chronic inflammation, oxidative stress, gluconeogenesis, and placental factors contribute to the pathology of GDM [2].”
BackgroundMoumne, O., Hampe, M. E., Montoya‐Williams, D., Carson, T. L., Neu, J., Francois, M., Rhoton-Vlasak, A. S., & Lemas, D. J. (2021) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0367 · Cited by 54
“5% of pregnancies worldwide and is associated with poor maternal and fetal outcomes, including cardiovascular disease and diabetes, fetal macrosomia, congenital malformations, and fetal hypoglycemia [25].”
BackgroundStelmach, A., Guzek, K., Rożnowska, A., Najbar, I., & Sadakierska−Chudy, A. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00440-6 · Cited by 37
“It is well known that the disturbance in glucose during pregnancy can increase the risk of gestational mellitus diabetes [20].”
BackgroundLu, H., Cao, W., Zhang, L., Liu, Y., Bi, X., Lin, Y., Deng, W., Jiang, T., Sun, F., Zeng, Z., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122048 · Cited by 37
“According to the findings of another study, chronic HBV infection was linked to a marginally increased risk of low birth weight and preterm birth, but HBeAg positivity led to an increased risk of low birth weight, preterm birth, and GDM (26).”
BackgroundInfluentialMazumder, H., Rimu, F. H., Shimul, M. M. H., Das, J., Gain, E. P., Liaw, W. R., & Hossain, M. M. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.169792 · Cited by 39
Serum metabolomic signatures of gestational diabetes in South Asian and white European women
Sikorski, C., Azab, S. M., de Souza, R. J., Shanmuganathan, M., Desai, D., Teo, K. K., Atkinson, S. A., Morrison, K. M., Gupta, M., Britz‐McKibbin, P., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002733 · Cited by 31
Pathophysiological Role of Genetic Factors Associated With Gestational Diabetes Mellitus
Ortega-Contreras, B., Armella, A., Appel-Rubio, J., Mennickent, D., Araya, J., González, M., de Castro, E. M. S., Obregón, A. M., Lamperti, L., Gutiérrez, J., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.769924 · Cited by 36
Broni, E. K., Ndumele, C. E., Echouffo-Tcheugui, J. B., Kalyani, R. R., Bennett, W. L., & Michos, E. D. (2022) · Current Diabetes Reports · doi:10.1007/s11892-021-01444-x · Cited by 35
Debele, T. A., & Park, Y. C. (2022) · Life · doi:10.3390/life12122078 · Cited by 38
“Research studies have shown GDM has many risk factors, including being overweight, obesity, oral contraceptive use, micronutrient deficiencies, or advanced maternal age, which are directly or indirectly correlated with impaired β-cell function and/or insulin resistance [36,37].”
BackgroundHasain, Z., Roos, N. A. C., Rahmat, F., Mustapa, M., Ali, R. A. R., & Mokhtar, N. M. (2021) · Nutrients · doi:10.3390/nu13093045 · Cited by 39
Gajera, D., Trivedi, V., Thaker, P., Rathod, M., & Dharamsi, A. T. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2061-9441 · Cited by 45
“However, in GDM, β-cells fail to compensate for increased blood glucose levels and, when combined with reduced insulin sensitivity, this results in hyperglycemia [8].”
BackgroundPaeoniflorin attenuates gestational diabetes via Akt/mTOR pathway in a rat model
Zhang, Y., Liang, Y., Liu, H., Huang, Y. K., Li, H., & Chen, B. (2020) · Food & Nutrition Research · doi:10.29219/fnr.v64.4362 · Cited by 32
“7–12% of pregnant women may develop with GDM based on the different populations studied (2).”
BackgroundMethodMa, N., Bai, L., & Lü, Q. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s454826 · Cited by 40
“11 Currently, GDM screening during pregnancy typically involves an Oral Glucose Tolerance Test (OGTT) administered at 24 to 28 weeks gestation, providing limited time for at-risk pregnant women to mitigate blood glucose levels through dietary, exercise, or medical interventions.”
MethodSelf-Management Mobile Virtual Reality Program for Women with Gestational Diabetes
Kim, S.-H., Kim, H. J., & Shin, G. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041539 · Cited by 31
“GDM etiology is related to pancreatic beta-cell dysfunction and marked insulin resistance secondary to placental hormonal release [7].”
BackgroundXu, P., Dong, S., Wu, L., Bai, Y., Bi, X., Li, Y., & Shu, C. (2022) · Nutrients · doi:10.3390/nu15010070 · Cited by 36
“In the bodies of normal pregnant women, the level of LEP in the early pregnancy is 2–3 times higher than that in the non-pregnancy period, and gradually increases [30].”
BackgroundEpigenetic Alterations Related to Gestational Diabetes Mellitus
Valencia‐Ortega, J., Saucedo, R., Sánchez-Rodríguez, M. A., Cruz-Durán, J. G., & Ramos-Martínez, E. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179462 · Cited by 36
“In women who develop GDM, there is a defect in the response of β cells that compensates for insulin resistance, which becomes evident in late pregnancy, when insulin resistance is greatest [14].”
BackgroundOdenkirk, M. T., Stratton, K. G., Gritsenko, M. A., Bramer, L., Webb‐Robertson, B., Bloodsworth, K., Weitz, K., Lipton, A. K., Monroe, M. E., Ash, J. R., et al. (2020) · Molecular Omics · doi:10.1039/d0mo00074d · Cited by 34
The Autism Spectrum Disorder and Its Possible Origins in Pregnancy
Botelho, R. M., Silva, A. L. M., & Borbely, A. U. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21030244 · Cited by 51
“The underlying pathophysiology of GDM involves modifications in the β -cells of the pancreas, caused by excess human placental lactogen hormone (hPL) [107].”
BackgroundEpigenetic Links between Microbiota and Gestational Diabetes
Mora-Janiszewska, O., Faryniak-Zuzak, A., & Darmochwał-Kolarz, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031831 · Cited by 28
The Maternal Microbiome and Gestational Diabetes Mellitus: Cause and Effect
Dias, S. C., Pheiffer, C., & Adam, S. (2023) · Microorganisms · doi:10.3390/microorganisms11092217 · Cited by 39
“The pathophysiological mechanisms that underlie the development of GDM are not yet fully understood, although it has been proposed that GDM develops in women who are unable to adapt to insulin resistance [21].”
Nutrition as Prevention Factor of Gestational Diabetes Mellitus: A Narrative Review
Mierzyński, R., Poniedziałek‐Czajkowska, E., Sotowski, M., & Szydełko-Gorzkowicz, M. (2021) · Nutrients · doi:10.3390/nu13113787 · Cited by 43
“It has been proven that GDM is also connected with antenatal depression more so than in normal pregnancy [5].”
BackgroundInfluentialHassan, A., Ahmad, S. G., Iqbal, T., Munir, E. U., Ayyub, K., & Ramzan, N. (2025) · International Journal of Computational Intelligence Systems · doi:10.1007/s44196-025-00760-4 · Cited by 39
“Once the GDM occurs, it elevates blood sugar levels [6].”
Tagoma, A., Haller‐Kikkatalo, K., Oras, A., Roos, K., Kirss, A., & Uibo, R. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13828 · Cited by 30
Placental metabolic profiling in gestational diabetes mellitus: An important role of fatty acids
Yang, Y., Pan, Z., Guo, F., Wang, H. H., Long, W., Wang, H., & Yu, B. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24096 · Cited by 35
α-Glucosidase Inhibitors for Diabetes/Blood Sugar Regulation
Bhatnagar, A., & Mishra, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-0932-0_12 · Cited by 60
Bennett, G., King, N., Redfern, K. M., & Breese, B. C. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2022.2155043 · Cited by 35
“The data extracted from each paper was as follows [1]: the first author’s last name [2]; the publication year [3]; the country in which the study took place [4]; the study population size (n) [5]; the participant characteristics (including age, body mass index and health parameters) [6]; the gestation week that interv…”
Continuous Glucose Monitoring for the Diagnosis of Gestational Diabetes Mellitus: A Pilot Study
Filippo, D. D., Ahmadzai, M., Chang, M. H. Y., Horgan, K., Ong, R. M., Darling, J., Akhtar, M., Henry, A., & Welsh, A. W. (2022) · Journal of Diabetes Research · doi:10.1155/2022/5142918 · Cited by 34
“It reflects maternal physiological inability to compensate for the progressive insulin resistance of pregnancy [2].”
BackgroundAmirani, E., Asemi, Z., & Taghizadeh, M. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.02.010 · Cited by 34
Hosni, A., El-Twab, S. M. A., Abdul‐Hamid, M., Prinsen, E., AbdElgawad, H., Abdel‐Moneim, A., & Beemster, G. T. S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105426 · Cited by 31
Tatsuta, N., Iwai‐Shimada, M., Nakayama, S. F., Iwama, N., Metoki, H., Arima, T., Sakurai, K., Anai, A., Asato, K., Kuriyama, S., et al. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113231 · Cited by 34
Role of ferritin and oxidative stress index in gestational diabetes mellitus
Gautam, S., Alam, F., Moin, S., Noor, N., & Arif, S. H. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00911-2 · Cited by 36
“Genetic, epigenetic, and environmental factors may all contribute to the development of GDM; there is evidence of adipose expandability, low-grade chronic inflammation, gluconeogenesis, oxidative stress, and some placental factors contributing to the pathogenesis of GDM [3].”
BackgroundVolqvartz, T., Andersen, H. H., Pedersen, L. H., & Larsen, A. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.16184 · Cited by 33
“…et al., 2020; Canto-Cetina et al., 2018; Gasse et al., 2019; Robillard et al., 2019; Shen et al., 2017), gestational diabetes mellitus (GDM) (Chen et al., 2020; Kim et al., 2013; Plows et al., 2018; Shen et al., 2017) and preterm birth (Chen et al., 2020; Sohlberg et al., 2012).”
BackgroundPhysical activity throughout pregnancy is key to preventing chronic disease
S Nagpal, T., & F Mottola, M. (2020) · Reproduction · doi:10.1530/rep-20-0337 · Cited by 29
“Exercise is considered an adjunctive therapy for women diagnosed with GDM by medical societies (Hopkins & Artal 2013); and there may be many mechanistic explanations for why exercise during pregnancy can also be protective against the development of GDM.”
BackgroundInfluentialHelmersen, M., Sørensen, M., Lukasse, M., Laine, H. K., & Garnweidner-Holme, L. M. (2021) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2021.1882077 · Cited by 39
Talebi, S., Mehrabani, S., Ghoreishy, S. M., Wong, A., Moghaddam, A., Rahimi-Feyli, P., Amirian, P., Zarpoosh, M., Kermani, M. A. H., & Moradi, S. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06489-w · Cited by 41
“In pregnant women with GDM, pre-pregnancy reduced insulin sensitivity and β-cell dysfunction lead to hyperglycemia [119, 120].”
BackgroundPirotta, S., Joham, A., Grieger, J. A., Tay, C. T., Bahri-Khomami, M., Lujan, M., Lim, S. S., & Moran, L. J. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1726866 · Cited by 29
Jiao, Y., Zhang, S., Zhang, J., & Du, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01197-y · Cited by 29
Extracellular vesicles and their role in gestational diabetes mellitus
James‐Allan, L. B., & Devaskar, S. U. (2021) · Placenta · doi:10.1016/j.placenta.2021.02.012 · Cited by 34
Mesquita, L. M. D. S., Mennitti, L. V., de Rosso, V. V., & Pisani, L. P. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa075 · Cited by 33
Sadiya, A., Jakapure, V., Shaar, G., Adnan, R., & Tesfa, Y. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04972-w · Cited by 38
“Lifestyle intervention has been found to be effective in preventing T2D in individuals with impaired glucose tolerance (“high-risk individuals”) [9–11].”
BackgroundInfluentialBigdeli, S. K., Ghazisaedi, M., Ayyoubzadeh, S. M., Hantoushzadeh, S., & Ahmadi, M. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02799-3 · Cited by 38
Altered islet prohormone processing: a cause or consequence of diabetes?
Ramzy, A., & Kieffer, T. J. (2021) · Physiological Reviews · doi:10.1152/physrev.00008.2021 · Cited by 33
Nde, A. L., Chukwuma, C. I., Erukainure, O. L., Chukwuma, M. S., & Matsabisa, M. G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114663 · Cited by 42
Perspectives from metabolomics in the early diagnosis and prognosis of gestational diabetes mellitus
Zhang, M., & Yang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.967191 · Cited by 35
“diabetes are risk factors for GDM (3).”
Najafi, M. L., Zarei, M., Gohari, A., Haghighi, L., Heydari, H., & Miri, M. (2020) · Environmental Health · doi:10.1186/s12940-020-00682-y · Cited by 32
Bulka, C. M., Everson, T. M., Burt, A., Marsit, C. J., Karagas, M. R., Boyle, K. E., Niemiec, S., Kechris, K. J., Davidson, E., Yang, I. V., et al. (2023) · Epigenetics · doi:10.1080/15592294.2023.2179726 · Cited by 40
“Abnormalities of the placenta have been proposed to underlie a myriad of pregnancy complications, including preterm labour [3], preeclampsia [4], gestational diabetes [5], placenta accreta [6], placental abruption [7], and intrauterine growth restriction [8], together affecting as many as 1 in 10 pregnancies.”
BackgroundDuo, Y., Song, S., Zhang, Y., Qiao, X., Xu, J., Zhang, J., Peng, Z., Chen, Y., Nie, X., Sun, Q., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm13010060 · Cited by 36
“With the change in maternal hormone levels in the first trimester of pregnancy, slight insulin resistance and increased insulin secretion may affect fetal growth and energy reserves [8].”
BackgroundBerger, B. O., Wolfson, C., Reid, L. D., & Strobino, D. M. (2020) · Women s Health Issues · doi:10.1016/j.whi.2020.08.008 · Cited by 35
Nazarpour, S., Tehrani, F. R., Valizadeh, R., & Amiri, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02037-z · Cited by 29
“GDM is a pathological exacerbation of the physiological increase in insulin resistance during pregnancy [37].”
BackgroundVarthaliti, A., Lygizos, V., Fanaki, M., Pergialiotis, V., Papapanagiotou, A., Pappa, K. I., Theodora, M. K., Daskalaki, M. A., Antsaklis, P. G., & Daskalakis, G. (2025) · Biomedicines · doi:10.3390/biomedicines13071627 · Cited by 38
“Gestational diabetes mellitus (GDM) is one of the most common metabolic disorders of pregnancy, affecting approximately 7–14% pregnancies worldwide [1].”
Effect of Mediterranean diet for pregnant women: a meta-analysis of randomized controlled trials
Zhang, Y., Xia, M., Weng, S.-Y., Wang, C., Yuan, P., & Tang, S. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1868429 · Cited by 33
Ke, W., Chen, Y., Zheng, L., Zhang, Y., Wu, Y., & Li, L. (2021) · Bioengineered · doi:10.1080/21655979.2021.2001219 · Cited by 27
“Gestational diabetes mellitus (GDM) is regarded as the most prevalent pregnancy complication, clinically manifested due to abnormal glucose intolerance and fasting glucose (≥92 mg/dL) that precipitates to chronic hyperglycemia and threatens safe pregnancy [1,2].”
BackgroundRetractedYang, J., Wu, J., Ayele, F. T., Li, L., Bremer, A. A., Lu, R., Rahman, M. L., Weir, N. L., Pang, W. W., Chen, Z., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1892 · Cited by 33
Soomro, M. H., England-Mason, G., Reardon, A. J. F., Liu, J., MacDonald, A. M., Kinniburgh, D. W., Martin, J. W., & Dewey, D. (2024) · Reproductive Toxicology · doi:10.1016/j.reprotox.2024.108612 · Cited by 32
Regulatory roles of extracellular vesicles in pregnancy complications
Sun, Q., Chang, H., Wang, H., Zheng, L., Weng, Y., Zheng, D., & Zheng, D. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.02.010 · Cited by 33
“Pregnancy is accompanied by a cascade of profound physiological transformations such as the significant hormonal, immunological, and metabolic changes in women, intricately orchestrated to support fetal implantation and development [1].”
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.